CVS Health Overview
CVS Health Target Price
Where could CVS trade next? Consensus target price: $110.
Get informed when a big investor buys or sells
+ FollowShare Price
$86.46
Average Target Price
$114.00
31.9% upside
31.9% upside16 analysts in the last 4 months
High: $126 | Low: $103
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-09 | Bernstein | $112 | 29.5% upside |  |
| 2026-09-09 | BMO Capital | $112 | 29.5% upside | |
| 2026-09-09 | Piper Sandler | $112 | 29.5% upside | |
| 2026-09-03 | UBS | $118 | 36.5% upside | |
| 2026-08-19 | Argus Research | $114 | 31.9% upside | |
| 2026-08-06 | Robert W. BairdMichael Ha | $107 | 23.8% upside | |
| 2026-08-06 | UBSKevin Caliendo | $126 | 45.7% upside | |
| 2026-08-06 | Barclays | $108 | 24.9% upside | |
| 2026-07-24 | UBS | $122 | 41.1% upside | |
| 2026-07-14 | Truist FinancialDavid MacDonald | $118 | 36.5% upside | |
| 2026-07-13 | Wells Fargo | $123 | 42.3% upside | |
| 2026-07-09 | RBC Capital | $113 | 30.7% upside | |
| 2026-07-07 | Cantor Fitzgerald | $110 | 27.2% upside | |
| 2026-07-06 | HSBC | $103 | 19.1% upside | |
| 2026-06-08 | Mizuho Securities | $115 | 33% upside | |
| 2026-06-04 | Morgan Stanley | $111 | 28.4% upside | |
| 2026-06-01 | Truist Financial | $108 | 24.9% upside | |
| 2026-06-01 | Piper SandlerJessica Tassan | $113 | 30.7% upside | |
| 2026-05-26 | BarclaysAndrew Mok | $106 | 22.6% upside | |
| 2026-05-20 | Mizuho Securities | $110 | 27.2% upside | |
| 2026-05-14 | Morgan Stanley | $106 | 22.6% upside | |
| 2026-05-13 | Bernstein | $106 | 22.6% upside | |
| 2026-05-07 | RBC Capital | $107 | 23.8% upside | |
| 2026-05-07 | Deutsche Bank | $92 | 6.4% upside | |
| 2026-05-07 | Truist Financial | $102 | 18% upside | |
| 2026-05-07 | BarclaysAndrew Mok | $101 | 16.8% upside | |
| 2026-04-15 | Robert W. Baird | $94 | 8.7% upside | |
| 2026-03-05 | Leerink PartnersMichael Cherny | $98 | 13.3% upside | |
| 2026-01-28 | Argus Research | $90 | 4.1% upside | |
| 2026-01-06 | Bernstein | $91 | 5.3% upside | |
| 2025-12-12 | Bernstein | $87 | 0.6% upside | |
| 2025-12-10 | Mizuho SecuritiesAnn Hynes | $95 | 9.9% upside | |
| 2025-12-10 | Robert W. Baird | $92 | 6.4% upside | |
| 2025-12-10 | Piper SandlerJessica Tassan | $101 | 16.8% upside | |
| 2025-12-10 | Morgan Stanley | $93 | 7.6% upside | |
| 2025-12-10 | Barclays | $93 | 7.6% upside | |
| 2025-12-10 | UBSKevin Caliendo | $97 | 12.2% upside | |
| 2025-12-10 | Truist Financial | $100 | 15.7% upside | |
| 2025-12-04 | Bernstein | $86 |  0.5% downside | |
| 2025-10-30 | RBC Capital | $93 | 7.6% upside | |
| 2025-10-24 | UBS | $96 | 11% upside | |
| 2025-10-14 | Truist FinancialDavid MacDonald | $92 | 6.4% upside | |
| 2025-10-14 | Morgan StanleyErin Wright | $89 | 2.9% upside | |
| 2025-10-14 | Goldman Sachs | $91 | 5.3% upside | |
| 2025-10-09 | Mizuho SecuritiesAnn Hynes | $88 | 1.8% upside | |
| 2025-10-07 | Wells Fargo | $103 | 19.1% upside | |
| 2025-09-04 | BarclaysAndrew Mok | $87 | 0.6% upside | |
| 2025-08-18 | UBSKevin Caliendo | $79 | 8.6% downside | |
| 2025-08-14 | Robert W. BairdMichael Ha | $82 | 5.2% downside | |
| 2025-06-02 | BarclaysAndrew Mok | $79 | 8.6% downside | |